ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Pain Medicine

Top Pain Medicine Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SUNIL ALBERT M.D.

Pain Medicine

1,249

$79.6K

154
101 are 65+

47%
patients receiving schedule two controlled substances

Avg: 30%

21%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $100

CHARLES KIM M.D.

Pain Medicine

480

$74.4K

52
38 are 65+

40%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$155
Average prescription price

Avg: $100

LUCIANO TULUCA MD

Pain Medicine

1,267

$80K

204
120 are 65+

46%
patients receiving schedule two controlled substances

Avg: 30%

17%
patients receiving schedule three controlled substances

Avg: 18%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $100

STACEY JAFF M.D.

Pain Medicine

169

$13.7K

27
0 are 65+

48%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$81
Average prescription price

Avg: $100

JOSHUA REIMER MD

Pain Medicine

597

$25.2K

172
139 are 65+

13%
patients receiving schedule two controlled substances

Avg: 30%

20%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $100

LUKE RIGOLOSI MD

Pain Medicine

499

$38.8K

140
103 are 65+

19%
patients receiving schedule two controlled substances

Avg: 30%

39%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 24%

$78
Average prescription price

Avg: $100

SEEMA NAMBIAR MD

Pain Medicine

955

$112K

115
69 are 65+

33%
patients receiving schedule two controlled substances

Avg: 30%

16%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 24%

$118
Average prescription price

Avg: $100

SANJEEV AGARWAL M.D.

Pain Medicine

656

$22K

224
139 are 65+

11%
patients receiving schedule two controlled substances

Avg: 30%

38%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 24%

$34
Average prescription price

Avg: $100

ALEXANDER LEE MD

Pain Medicine

832

$61.5K

229
193 are 65+

15%
patients receiving schedule two controlled substances

Avg: 30%

21%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $100

SYED HUSAIN D.O.

Pain Medicine

547

$50.7K

126
74 are 65+

29%
patients receiving schedule two controlled substances

Avg: 30%

12%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$93
Average prescription price

Avg: $100

ENRIQUE SANZ M.D.

Pain Medicine

297

$11.3K

108
60 are 65+

16%
patients receiving schedule two controlled substances

Avg: 30%

30%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $100

THOMAS JAN D.O.

Pain Medicine

1,200

$234K

197
92 are 65+

53%
patients receiving schedule two controlled substances

Avg: 30%

17%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 24%

$195
Average prescription price

Avg: $100

STEVEN CALVINO M.D.

Pain Medicine

632

$56.4K

63
41 are 65+

40%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 24%

$89
Average prescription price

Avg: $100

LEE TROSTERMAN MD

Pain Medicine

820

$93.5K

207
101 are 65+

34%
patients receiving schedule two controlled substances

Avg: 30%

14%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 24%

$114
Average prescription price

Avg: $100

MATTHEW KALTER M.D.

Pain Medicine

808

$90.3K

128
72 are 65+

40%
patients receiving schedule two controlled substances

Avg: 30%

22%
patients receiving schedule three controlled substances

Avg: 18%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 24%

$112
Average prescription price

Avg: $100

JOSEPH HERRERA D.O.

Pain Medicine

479

$64.7K

85
58 are 65+

28%
patients receiving schedule two controlled substances

Avg: 30%

18%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 24%

$135
Average prescription price

Avg: $100

JASON LIPETZ M.D

Pain Medicine

299

$8,152

168
159 are 65+

15%
patients receiving schedule two controlled substances

Avg: 30%

8%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 24%

$27
Average prescription price

Avg: $100

JOSEPH SANELLI D.O.

Pain Medicine

111

$4,814

51
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $100

SAMANT VIRK MD

Pain Medicine

564

$46.7K

130
71 are 65+

30%
patients receiving schedule two controlled substances

Avg: 30%

8%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $100

DMITRY NESEN M.D.

Pain Medicine

351

$23.9K

59
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $100

EVAN QUELER M.D.

Pain Medicine

201

$13.3K

75
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $100

LARISA TSAUR MD

Pain Medicine

942

$111K

91
60 are 65+

19%
patients receiving schedule two controlled substances

Avg: 30%

18%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 24%

$118
Average prescription price

Avg: $100

HOWARD ADELGLASS MD

Pain Medicine

1,187

$135K

169
143 are 65+

14%
patients receiving schedule two controlled substances

Avg: 30%

12%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$114
Average prescription price

Avg: $100

RENEE MELFI MD

Pain Medicine

911

$68.9K

193
157 are 65+

7%
patients receiving schedule two controlled substances

Avg: 30%

14%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $100

SYED RAHMAN M.D.

Pain Medicine

640

$35.8K

139
102 are 65+

12%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $100

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank